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Background: Aging causes profound changes of stiffness and compliance in the cardiovascular system, which 
contributes to decreased cardiovascular reserve. Mechanisms of the underlying endothelial vasodilator dysfunction 
in vasodilator signaling pathways may occur at multiple sites within any of these pathways. 
Methods: Age-related changes in the vasculature were investigated in adult young (3-6 months, Y) and old (26-
29 month, O) Wistar rats (n = 6). The aortas were carefully dissected from the rat and cut into rings 1.5-2.0 mm in 
length to measure in vitro isometric tension. Vasorelaxant responses of aortic rings to acetylcholine (ACh), sodium 
nitroprusside (SNP) and P1075 were examined using Dose Response software (AD Instruments, Mountain View, CA). 
Results: Endothelium-dependent vasodilator function was impaired. The endothelium of aging rats impaired 
endothelial NO dependent vasodilation, but the machinery for vasodilation was not impaired. 
Conclusions: Age-related NO-mediated vasorelaxation in the aging endothelium was inhibited and appears to be 
major mechanism of vascular change and impaired vascular regulation. (Korean J Anesthesiol 2011; 61: 506-510)
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Introduction
Aging has been identified as the dominant risk factor for 
cardio  vascular disease [1]. Further, animal studies have con-
sistently reported, that age-related endothelial dysfunction in 
the vascular system plays an important role in cardiovascular 
disease [2-6]. Nitric oxide (NO) is an important factor involved 
in endothelial regulation of vascular function. In experi  mental 
animal models of aging, it has been reported that NO bio-
availability is decreased, due to an increased production of 
superoxide anion and peroxynitrite (ONOO
-) [7,8]. Vascular 
endothelial dysfunction occurs during the human aging 
process, and it is considered as a crucial event in the develop-
ment of many vasculopathies. We investigated the underlying 
mechanisms of this process. The characteristic changes 
in aging vasculature include endothelial dysfunction. The 
mechanisms of underlying endothelial dysfunction, defined 
as impaired vasodilator response to agonists involve multiple 
signaling pathways. Age-associated vasodilator dysfunction 
results from an increased production of ROS which limits the 
bioavailability of NO or leads to a relative deficiency of substrate 
for the synthesis of NO. To test this hypothesis we measured 
vasoreactivity to endothelium dependent and independent 
vasodilators. We also examined the effect of vasodilator 507 www.ekja.org
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function in aging rats and young rats.
Materials and Methods
Wistar rats, 3-6 months of young age and 26-29 months of 
old age weighing 400-500 g, were housed separately at 22
oC. 
The animals were fed regular rat chow and water ad libitum. 
The study was approved by the Institutional Animal Care and 
Use Committee. Animals were anesthetized with ketamine-
xylazine, and the aorta were rapidly removed and placed in 
ice-cold oxygenated Krebs-Ringer physiological buffer. The 
aortic rings with endothelium (ED+) were carefully dissected 
from the rat and cut into rings 1.5-2.0 mm in length for in 
vitro isometric tension measurements. A subset of aortic rings 
had the endothelium removed (ED-) by gentle rubbing of 
the luminal surface with a stainless steel rod. The completion 
of ED- was confirmed by the obliteration of the vasorelaxant 
response to the endothelium dependent agonist ACh. For the 
in vitro isometric tension measurements, aortic rings were 
suspended in 5 ml organ chambers. The rings were mounted 
horizontally between two stainless steel stirrups. One of the 
stirrups was anchored to a micromanipulator and the other 
to a force transducer (FT-03) in a myograph (150 μm stirrups) 
(Mangus, Iwashiya Kishimoto Medical Instruments, Kyoto, 
Japan). All dose-response curves were performed on vessel 
rings beginning at their optimum resting tone. All of the aortic 
rings were stretched to 3,000 mg in 500 mg increments over a 1 
hour period to optimize the contractile responses. Aortic rings 
were equilibrated in oxygenated cold modified Krebs-Ringer 
bicarbonate buffer with the following composition (mM); 118.3 
NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2, 25 NaHCO3, 
0.016 Ca-EDTA, and 11.1 glucose(control solution). Buffer was 
purged with 95% O2, 5% CO2 and maintained at pH 7.4 and 
37
oC. Optimal resting tone was the minimum level of stretch 
allowed for the largest contractile response to KCl (60 mM). 
After aortic rings had been stretched to their optimal resting 
tone, contractile response to 60 mM KCl was determined. After 
removal of KCl, all vessel rings were constricted by phenyle-
phrine (PE: 10
-9 to 10
-4 M). To test the vasorelaxant capability 
of the vessel rings, they were preconstricted by PE (10
-6 M), and 
then vasorelaxant responses to acetylcholine (ACh:10
-9 to 10
-5 
M), sodium nitroprusside (SNP:10
-9 to 10
-5 M) and P1075 (10
-9 to 
10
-4 M) were determined in vessels from old and young rats. Data 
were collected on-line by using a MacLab system and analyzed 
by using Dose-Response software (AD Instruments, Mountain 
View, CA). In all experiments, vasoconstrictor responses were 
expressed as tension in milligrams. ED50 and maximal response 
(Emax) were calculated by using nonlinear logistic regression 
analysis with the PRIZM
Ⓡ software (Graphpad, Mountain View, 
CA). All data are reported as means ± SD. Statistical differences 
were determined by using a Student’s t-test (paired t-test for 
within group comparisons and an unpaired t-test for between 
group comparisons).
Results
Responses to PE
PE (10
-9 to 10
-4 M) induced concentration-dependent con-
t  rac      tions in isolated old and young rat aortic rings (Fig. 1). 
The con  cen    tration effect curves to PE statistically showed no 
differenc    e of contraction in ED+ aortic rings from old and young 
rats (Emax, 1,784 ± 66 mg vs. 1,857 ± 34 mg; log ED50, -7.22 ± 0.12 
vs. -7.27 ± 0.06 in old vs. young rats, respectively; n = 6, Fig. 1). 
The concent  ration effect curves to PE also showed no difference 
of contraction in ED- aortic rings from old and young rats (Emax, 
2,222 ± 47 mg vs. 2,205 ± 36 mg; log ED50, -7.38 ± 0.07 vs. -7.61 
± 0.06 in old vs. young rats respectively; n = 6, Fig. 1).
ACh, SNP, and P1075 evoked concentration-dependent 
relaxations
ACh (10
-9 to 10
-5 M) evoked more relaxation of endothelium 
containing rings in young rats than old rats (Emax, 72.4 ± 2.8% vs. 
43.6 ± 1.7%; log ED50, -7.700 ± 0.17 vs. -7.491 ± 0.12 in young 
vs. old rats, respectively; P < 0.05; n = 6; Fig. 2). ACh-induced 
relaxation in aortic rings of old and young rats was abolished by 
denuding of the endothelium; Fig. 2). The relaxations induced 
by SNP (10
-9 to 10
-5 M) in the ED+ vascular rings showed some 
differences in both groups. (Emax, 101.9 ± 2.4% vs. 84.2 ± 1.9%; 
log ED50, -7.76 ± 0.07 vs. -7.327 ± 0.06 in young vs. old rats, 
respectively; n = 6; Fig. 3). But the relaxations to P1075 (10
-9 to 10
-4 
Fig. 1. PE dose-response curves of vessels from young and old rats (n 
= 6). Responses are expressed as tension (mg) and are presented as 
means ± SD in ED+ and ED- vessels.508 www.ekja.org
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M) in ED+ vascular rings were similar in both groups. (Emax, 93.1 
± 5.0% vs. 103.0 ± 5.5%; log ED50, -5.58 ± 0.13 vs. -5.36 ± 0.12 
in young vs. old rats, respectively, n = 6; Fig. 4). The relaxation 
by SNP of ED- vascular rings were similar in both groups (Emax, 
100.6 ± 2.1% vs 99.0 ± 1.9%; log ED50, -7.79 ± 0.07 vs. -7.49 ± 0.06 
in young vs. old rats, respectively; n = 6; Fig. 5). The relaxation 
by P1075 of ED- vascular rings were also similar in both groups 
(Emax, 90.7 ± 7.3% vs 98.2 ± 9.7%; log ED50, -5.09 ± 0.13 vs. -4.04 
± 0.14; in young vs. old rats, respectively; n = 6; Fig. 4).
Discussion
Numerous changes have been described in the cardiovascular 
system by aging. Examples of these changes include elastance 
and compliance changes in the arterial tree resulting in increased 
cardiac load as well as, impaired beta adrenergic receptor 
signaling in the heart and vasculature. Mechanisms underlying 
endothelial vasodilator dysfunction in the vasodilator signaling 
pathways may occur at multiple sites within any of these 
Fig. 2. ACh dose-response curves of vessels from young and old rats 
(n = 6). Vasorelaxant responses are expressed as a percentage of Emax 
after preconstriction with PE (10
-6 M) and are presented as means 
± SD in ED+ and ED- vessels. The vasorelaxant Emax to ACh was 
attenuated in ED+ aortic rings from old rats (*P < 0.05), compared 
with young rats. There were no responses to ACh in ED- vessels.
Fig. 3. SNP dose-response curves of vessels from young and old rats 
(n = 6). Vasorelaxant responses are expressed as a percentage of Emax 
after preconstriction with PE (10
-6) and are presented as means ± SD 
in ED+ vessels. The vasorelaxant Emax to SNP was not significantly 
different in ED+ aortic rings from old rats, compared with young rats.
Fig. 5. SNP dose-response curves of vessels from young and old rats 
(n = 6). Vasorelaxant responses are expressed as a percentage of Emax 
after precontriction with PE (10
-6) and are presented as means ± SD 
in ED- vessels. The vasorelaxant Emax to SNP was similar in ED- 
aortic rings from old rats, compared with young rats.
Fig. 4. P1075 dose-response curves of vessels from young and old 
rats (n = 6). Vasorelaxant responses are expressed as a percentage 
of Emax after preconstriction with PE (10
-6 M) and are presented as 
means ± SD in ED+ and ED- vessels. The vasorelaxant Emax to P1075 
was similar in ED+ and ED- aortic from old and young rats. 509 www.ekja.org
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pathways. With regard to the nitric oxide (NO) pathway, 
abnormalities may occur secondarily to disturbances in 
the availability of substrate, receptor/G-protein signaling 
in the endothelial cell, the activity or expression of nitric 
oxide synthase (NOS), the bioavailability of NO and vascular 
smooth muscle signaling and relaxation. Decreases in the 
bioavailability of NO have been proposed as a mechanism of 
vasodilator/endothelial dysfunction in several diseases such 
as atherosclerosis, hypertension, and hypercholesterolemia. 
Moreover, endogenous inhibitors of NOS have recently been 
proposed as a possible mechanism for underlying vasodilator 
dysfunction in peripheral vascular disease and hypertension. 
Hypertension and hypercholesterolemia, two established 
risk factors for cardiovascular disease are common in the 
aging population. It is well recognized that endothelial 
dysfunction occurs in these two diseases. It has also becoming 
increasingly evident that vasodilator dysfunction occurs in 
aging independent of hypercholesterolemia and hypertension. 
Endothelial nitric oxide synthase (eNOS) is the enzyme 
expressed in endothelial cells that produces nitric oxide (NO), 
the most important vasodilatory molecule synthesized by the 
endothelium [9]. The most prominent mediators of endothelium 
dependent dilatation are NO and prostacyclin(PGI2), 
which cause relaxation by stimulating guanylyl cyclase and 
adenylyl cyclase, respectively. Responses that are resistant 
to blockade of NOS and cyclooxygenase are associated with 
endothelium dependent hyperpolarization of vascular smooth 
muscle, and they are thought to be mediated by a distinct 
endothelium derived hyperpolarizing factor (EDHF)[10]. ACh 
produces dilatation in essentilly all vascular beds, including 
the pulmonary and coronary vascular beds [11]. Coronary 
vasodilatation may be elicited by either a cardiovascular 
reflex or by direct electrical stimulation of the vagus. The 
dilatation of vascular beds by choline esters is due to the 
presence of muscarinic receptors, primarily of the M3 subtype 
[12], despite the lack of apparent cholinergic innervation 
of most blood vessels. The muscarinic receptors which are 
responsible for relaxation are located on the endothelial cells 
of the vasculature; when these receptors are stimulated, the 
endothelial cells release NO (endothelium-derived relaxing 
factor)[13], which diffuses to adjacent smooth muscle cells 
and causes them to relax. If the endothelium is damaged, 
ACh can stimulate receptors on vascular smooth muscle cells 
and cause vasoconstriction. Although SNP has been known 
since 1850 and its hypotensive effect in human beings was 
described in 1929, its safety and usefulness for the short-term 
control of severe hypertension was not demonstrated until the 
mid-1950s. It is a nitro-vasodilator, metabolized by smooth 
muscle cells to its active metabolite, nitric oxide. NO activates 
guanylate cyclase, leading to the formation of cyclic GMP and 
vasodilatation [14]. The metabolic activation of SNP is catalyzed 
by a different NO generating system than nitroglycerin (NTG), 
which probably accounts for the difference in potency between 
these drugs at different vascular sites in addition to the fact 
that tolerance develops to NTG but not to SNP [15]. SNP dilates 
both arterioles and venules, and the hemodynamic response 
to its administration results from a combination of venous 
pooling and reduced arterial impedance. Its onset of action is 
within 30 seconds; the peak hypotensive effect occurs within 
2 minutes, and when the infusion of the drug is stopped, the 
effect disappears within 3 minutes. The metabolism of SNP by 
smooth muscle is initiated by its reduction, which is followed 
by the release of cyanide and then nitric oxide [16]. The ATP-
sensitive K channel (KATP) opener, P1075{N-cyano-N’'-(1,1-
dimethylpropyl)-N’'’'-3-pyridylguanidine}, is a cyanoguanidine 
drug that opens ATP-sensitive potassium channels producing 
peripheral vasodilatation of arterioles and a pinacidil analogue, 
an established opener of KATP channels [17,18]. Age related 
changes in the vasculature were investigated in old (26-29 
months) and adult young (3-6 months) Wistar rats. Vaso-
relaxant responses were examined in aortic rings. PE-induced 
constriction of vessels harvested from old and young rats were 
not statistical difference (ED+; maximal response, 1,784 ± 66 
mg vs. 1,857 ± 34 mg; log ED50, -7.22 ± 0.12 vs. -7.27 ± 0.06 in 
old vs. young rats, respectively; ED-; maximal response, 2,222 
± 47 mg vs. 2,205 ± 36 mg; log ED50, -7.38 ± 0.07 vs. -7.61 ± 
0.06 in old vs. young rats, respectively) (Fig. 1). Following PE 
preconstric  tion, ACh-induced does-dependent relaxation was 
profoundly attenuated in rings of old rats (Emax, 72.4 ± 2.8% vs. 
43.6 ± 1.7%, log ED50, -7.700 ± 0.17 vs. -7.491 ± 0.12 in old 
and young rats, respectively, P < 0.05, n = 6; Fig. 2). SNP, like 
endogenous NO, also activates cGMP-dependent mechanisms 
within vascular smooth muscle. SNP-induced relaxation was 
also impaired in ring from old rats (ED+; Emax, 101.9 ± 2.4% vs. 
84.2 ± 1.9%; log ED50, -7.76 ± 0.07 vs. -7.327 ± 0.06 in young 
and old rats, respectively, P > 0.05; n = 6; Fig. 3). The impaired 
vasorelaxant response in ED+ vessels from old rats was not 
observed in ED- vessels. The magnitude of the differential 
response in old versus young rats was similar in ED- rings. 
However, the dose response to SNP in ED+ vessels from old 
rats was shifted to the right, suggesting a modulating (inhibitory) 
influence of the endothelium in the response to SNP. Relaxation 
of vascular smooth muscle is dependent on the integrity of the 
contractile/relaxation machinery. This system can be activated 
by a number of pathways including those dependent on NO/
cGMP, and pathways independent of NO but dependent 
on membrane polarization. To determine the specificity of 
our observation, we investigated changes in ATP-sensitive 
potassium (K
+
ATP) channel activation, which were assessed by 
constructing dose responses with the channel opener P1075. 510 www.ekja.org
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The vasorelaxant responses to P1075 were identical in vessels 
from old and young rats (Fig. 4). Aortic rings have been utilized 
most frequently to assess vascular changes because of their 
accessibility and size. In ED+ aortic rings, both the ACh and 
SNP-curves were shifted to the right in all rats implying impaired 
vasorelaxant responses in old versus young. The maximal 
vasodilator response to ACh was profoundly impaired in aortic 
rings. In sum, removal of the endothelium abolished ACh 
response in old and young rats, and ACh vasorelaxant responses 
markedly attenuated in aortic rings from aging rats. SNP-induced 
vasorelaxation was no different in ED- rings from old and young 
rats. In contrast, vasorelaxant response to SNP is more attenuated 
in vessels from old rats in ED+ rings. This suggests that the 
endothelium is inhibiting NO mediated vasorelaxation, possibly 
by decreasing its bioavalability. In order to determine whether 
machinery involved in the vasodilatory mechanisms which 
are impaired in vascular rings from aging rats, the vasorelaxant 
responses to P1075, a K
+ channel activator was tested . There 
was no significant difference in the vasorelaxant responses to 
hyperpolarization suggesting that vasorelaxant machinery distal 
to the NO pathway is intact. In conclusion, one mechanism 
of underlying age-related vascular changes was impaired in 
vascular regulation. In particular, aging endothelium was 
inhibiting NO-mediated vasorelaxation.
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